Claims
- 1. A process for producing aspartyl dipeptide ester derivative represented by formula (2), which comprises:
reductively alkylating aspartame with the aldehyde represented by formula (1): 8wherein R1, R2, R3, R4 and R5 are independently selected from the group consisting of a hydrogen atom, a hydroxyl group, an alkoxy group having 1 to 3 carbon atoms, an alkyl group having 1 to 3 carbon atoms, a benzyloxy group and a hydroxyalkyloxy group having 2 or 3 carbon atoms, wherein R1 and R2, or R2 and R3 form a methylene dioxy group, and provided that in formula (2), any one of R1, R2, R3, R4 and R5 does not represent a benzyloxy group.
- 2. The process as defined in claim 1, wherein R3 is a methoxy group, and R1, R2, R4 and R5 are hydrogen atoms.
- 3. The process as defined in claim 1, wherein R3 is a hydroxyl group, and R1, R2, R4 and R5 are hydrogen atoms, and in formula (1) R3 is a hydroxyl group or a benzyloxy group.
- 4. The process as defined in claim 1, wherein R2 is a methoxy group, R3 is a hydroxyl group, and R1, R4 and R5 are hydrogen atoms, and in formula (1) R3 is a is a hydroxyl group or a benzyloxy group.
- 5. The process as defined in claim 1, wherein R2 is a hydroxyl group, R3 is a methoxy group, and R1, R4 and R5 are hydrogen atoms, and in formula (1) R2 is a is a hydroxyl group or a benzyloxy group.
- 6. The process as defined in claim 1, wherein R1 is a hydroxyl group, and R2, R3, R4 and R5 are hydrogen atoms, and in formula (1), R1 is a hydroxyl group or a benzyloxy group.
- 7. The process as defined in claim 1, wherein R1 is a hydroxyl group, R3 is a methoxy group, and R2, R4 and R5 are hydrogen atoms, and in formula (1) R1 is a hydroxyl group or a benzyloxy group.
- 8. The process as defined in claim 1, wherein R1 is a hydroxyl group, R3 is a methyl group, and R2, R4 and R5 are hydrogen atoms, and in formula (1) R1 is a hydroxyl group or a benzyloxy group.
- 9. The process as defined in claim 1, wherein R2 and R3 are combined to represent a methylene dioxy group, and R1, R4 and R5 are hydrogen atoms.
- 10. The process as defined in claim 1, wherein R2 is a methyl group, R3 is a methoxy group, and R1, R4 and R5 are hydrogen atoms.
- 11. The process as defined in claim 1, wherein R2 is a methyl group, R3 is a hydroxyl group, and R1, R4 and R5 are hydrogen atoms, and in formula (1) R3 is a hydroxyl group or a benzyloxy group.
- 12. The process as defined in claim 1, wherein R2 is a hydroxyl group, R3 is a methyl group, and R1, R4 and R5 are hydrogen atoms, and in formula (1) R2 is a hydroxyl group or a benzyloxy group.
- 13. The process as defined in claim 1, wherein the reductive alkylating is conducted in the presence of hydrogenation catalyst.
- 14. The process as defined in claim 13, wherein said hydrogenation catalyst is palladium carbon or platinum carbon.
- 15. The process as defined in claim 1, wherein the reductive alkylating is conducted in a solvent of an alcohol or a water-containing alcohol.
- 16. A process for producing 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutylaldehyde, which comprises:
converting a carboxyl group in 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyric acid to a formyl group.
- 17. The process as defined in claim 16, wherein said 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyric acid is produced by converting a halogen atom in 3-(3-halogeno-4-methoxyphenyl)-3-methylbutyric acid to a hydroxyl group.
- 18. The process as defined in claim 17, wherein said 3-(3-halogeno-4-methoxyphenyl)-3-methylbutyric acid is prepared by reacting 2-halogenoanisole with 3-methylcrotonic acid.
- 19. The process as defined in claim 17, wherein the halogen atom is a chlorine atom or a bromine atom.
- 20. The process as defined in claim 18, wherein the reacting of 2-halogenoanisole with 3-methylcrotonic acid comprises reacting in the presence of an acid.
- 21. The process as defined in claim 16, wherein said converting a carboxyl group into a formyl group comprises reducing a carboxylic acid to an aldehyde; or converting a carboxyl group into a hydroxymethyl group and converting the hydroxymethyl group into a formyl group.
- 22. A process for producing N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester, which comprises:
reductively alkylating the 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl aldehyde obtained by the process of claim 16 with aspartame
- 23. A process for producing N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester, which comprises:
reductively alkylating 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl aldehyde with aspartame.
- 24. A compound of formula (3):
- 25. A compound selected from the group consisting of
3-(3 -hydroxy-4-methoxyphenyl)-3-methylbutylaldehyde; 3-(3-chloro-4-methoxyphenyl)-3-methylbutyric acid; 3-(3-bromo-4-methoxyphenyl)-3-methylbutyric acid; 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyric acid; and 3-(3-hydroxy-4-methoxyphenyl)-3-methyl-1-butanol.
- 26. A process for producing N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester, which comprises:
subjecting N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester containing impurity to crystallize the compound.
- 27. The process as defined in claim 26, wherein said N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester containing impurity is obtained by reductively akylating aspartame and 3-(3-hydroxy-4-methoxyphenyl)-3-methylbutylaldehyde or a derivative thereof.
- 28. The process as defined in claim 26, wherein said impurity is one or more compounds selected from the group consisting of aspartame, an aspartame derivative, a peptide derivative, an amino acid, an amino acid derivative, an aldehyde and an aldehyde derivative.
- 29. The process as defined in claim 26, wherein a solvent used in the crystallization is selected from the group consisting of methanol, ethanol, isopropyl alcohol, acetone, methyl ethyl ketone, methyl isobutyl ketone, methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, tetrahydrofuran, acetonitrile toluene, mixtures thereof; and mixtures thereof with water.
- 30. The process as defined in claim 26, further comprising removing said impurity from said N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester by extracting said impurity with a solvent.
- 31. The process as defined in claim 30, wherein said solvent is selected from the group consisting of toluene, diethyl ether, chloroform, dichloromethane, hexane, ethyl acetate, propyl acetate, isopropyl acetate and butyl acetate.
- 32. A crystal of N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester, which exhibits peaks of diffractive X-ray in at least diffraction angles of 8.3°, 19.5° and 21.2° (2θ, CuKα ray) when determined by powder X-ray diffractometry.
- 33. A sweetening composition comprising the crystal of N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L-α-aspartyl]-L-phenylalanine 1-methyl ester as defined in claim 32 and a carrier or bulking agent.
- 34. A food or drink comprising the crystal as defined in claim 32 as an effective ingredient.
- 35. A process for sweetening a food or drink, comprising
adding the crystal as defined in claim 32 to a food, a beverage, or an intermediate product used for making the food or beverage, in an amount sufficient to sweeten said food or drink.
Priority Claims (4)
Number |
Date |
Country |
Kind |
11-288207 |
Oct 1999 |
JP |
|
11-288208 |
Oct 1999 |
JP |
|
11-294409 |
Oct 1999 |
JP |
|
11-328099 |
Nov 1999 |
JP |
|
CROSS-REFERENCE TO RELATED APPLICATION
[0001] The present application is a continuation application of PCT/JP00/06933 filed Oct. 4, 2000, the entire contents of which are incorporated by reference.
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/JP00/06933 |
Oct 2000 |
US |
Child |
10117205 |
Apr 2002 |
US |